This meeting took place in 2016


Here are the related meetings in 2017:
Biobetters and Next-Generation Biologics: Innovative Strategies for Optimally Effective Therapies (A7)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Antibodies as Drugs (X2)


Organizer(s) Peter D. Senter, Anna M. Wu, Alan J. Korman and Karl Dane Wittrup
March 6—10, 2016
Fairmont Chateau Whistler • Whistler, British Columbia Canada
Discounted Abstract Deadline: Nov 5, 2015
Abstract Deadline: Dec 8, 2015
Scholarship Deadline: Nov 5, 2015
Discounted Registration Deadline: Jan 7, 2016

Sponsored by Genentech, Inc., Genmab A/S, ImmunoGen, Inc., Mersana Therapeutics, MorphoSys AG, OncoMed Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc.


Summary of Meeting:
Monoclonal antibodies have had a pronounced impact in medicine and biology, with a broad array of approved agents that are used for the diagnosis, treatment and characterization of cancers, immunological disorders, and infectious diseases. Because of their exquisite target specificities, together with their favorable pharmacologic properties, antibodies are destined to have even increased clinical impact, particularly in diseases that are understood at the molecular level. This Keystone Symposia meeting will focus attention on many of the key advances in antibody-based technologies as well as on where the field is heading. Some of the critical topics to be covered include: 1) Antibody structure and function; 2) Engineered antibodies and antibody-like molecules for improved efficacy; 3) Antibody pharmacologic properties and biologic distribution; 4) Antibody-based therapies for cancer and infectious diseases; 5) Targeting costimulatory pathways and immunological checkpoints; 6) Antibodies as carriers of drugs, cytokines, radioisotopes and imaging agents; 7) Antibody mimetics; 8) Clinical advancements and challenges. This meeting has become an established forum that attracts both new investigators and leaders in the field, coming from academia, industry and research institutes around the globe. The goals of the meeting will be to address the critical issues facing the broad field of antibody-based therapeutics, provide an overview of recent advances and bring together interdisciplinary groups for the generation of new ideas and promising areas of investigation.

View Meeting Program

Scholarships/Awards

National Institute of Allergy and Infectious Diseases (NIAID) Scholarship Recipients

Rony Dahan
Rockefeller University, USA

Julia Carina Frei
Albert Einstein College of Medicine, USA

Jacob Petersburg
University of Minnesota, USA

Sheena N. Smith
University of Zurich, Switzerland